{"id":13899,"date":"2015-06-11T16:27:53","date_gmt":"2015-06-11T15:27:53","guid":{"rendered":"http:\/\/blog.cofb.cat\/?p=13899"},"modified":"2015-06-11T16:27:53","modified_gmt":"2015-06-11T15:27:53","slug":"dermofarmacia-atencio-farmaceutica-al-pacient-oncologic-i-us-de-dermoanalitzadors","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/ca\/2015\/06\/11\/dermofarmacia-atencio-farmaceutica-al-pacient-oncologic-i-us-de-dermoanalitzadors\/","title":{"rendered":"Dermofarm\u00e0cia: atenci\u00f3 farmac\u00e8utica al pacient oncol\u00f2gic i \u00fas de dermoanalitzadors"},"content":{"rendered":"<p>Tot i els aven\u00e7os en el tractament del c\u00e0ncer, els efectes secundaris que els pacients que lluiten contra aquesta malaltia poden patir s\u00f3n diversos. Sovint pensem en efectes com n\u00e0usees i debilitat, per\u00f2 tamb\u00e9 es produeixen alteracions de l\u2019aspecte f\u00edsic pels canvis que els tractaments provoquen en la pell o en els cabells. Els pacients oncol\u00f2gics plantegen alguns dels dubtes que tenen a la farm\u00e0cia, no nom\u00e9s generals sobre els tractaments i els efectes sist\u00e8mics, sin\u00f3 tamb\u00e9 sobre quins canvis est\u00e8tics es produiran i com poden millorar el seu benestar personal.<\/p>\n<p><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2015\/05\/curs-dermo-abril-1.jpg\"><img fetchpriority=\"high\" decoding=\"async\" class=\"alignright  wp-image-13906\" alt=\"curs-dermo-abril (1)\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2015\/05\/curs-dermo-abril-1.jpg\" width=\"357\" height=\"200\" \/><\/a>Si fa uns dies parl\u00e0vem al Blog del \u201c<a href=\"http:\/\/blog.cofb.cat\/maquillatge-dermatologic-corrector-per-ajudar-a-millorar-la-qualitat-de-vida-dels-pacients\/\">curs de maquillatge dermatol\u00f2gic corrector<\/a>\u201d, el mes d\u2019abril el Col\u00b7legi va acollir un altre curs innovador i amb un alt nivell de repercussi\u00f3 en el consell diari a la farm\u00e0cia: \u201cAtenci\u00f3 farmac\u00e8utica dermatol\u00f2gica al pacient oncol\u00f2gic\u201d. Una formaci\u00f3 espec\u00edfica\u00a0per adquirir els coneixements necessaris dels efectes secundaris cutanis que produeixen els tractaments oncol\u00f2gics i aix\u00ed poder assessorar els pacients de la farm\u00e0cia sotmesos a aquests tipus de ter\u00e0pies i que demanen consell sobre com cuidar la pell i millorar l\u2019aspecte f\u00edsic.<\/p>\n<p><span style=\"color: #888888;\"><b>El consell dermatol\u00f2gic en oncologia \u00e9s clau per millorar la qualitat de vida dels pacients<\/b>.<\/span><\/p>\n<p>Els alumnes van aprendre quins efectes cutanis produeixen els tractaments oncol\u00f2gics i com alleujar-los. El professorat del curs va estar format per un equip multidisciplinar:\u00a0<strong>Alba Catal\u00e0<\/strong>, dermat\u00f2loga de la Cl\u00ednica Dermatol\u00f2gica Dermik i adjunta de la Cl\u00ednica Plat\u00f3;<strong>\u00a0Sonia Fuentes<\/strong>, psic\u00f2loga cl\u00ednica i coordinadora de la Unitat de psico-oncologia de l\u2019ICO de Badalona;\u00a0<strong>Cristina L\u00f3pez<\/strong>, farmac\u00e8utica i responsable de Formaci\u00f3 de Laboratorios Av\u00e8ne, i <strong>Montserrat Mu\u00f1oz<\/strong>, onc\u00f2loga i responsable de la Unitat de Patologia Funcional de la Mama de l\u2019Hospital Cl\u00ednic de Barcelona.<\/p>\n<figure id=\"attachment_13907\" aria-describedby=\"caption-attachment-13907\" style=\"width: 255px\" class=\"wp-caption alignleft\"><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2015\/05\/curs-dermo-abril-4.jpg\"><img decoding=\"async\" class=\" wp-image-13907 \" alt=\"curs-dermo-abril\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2015\/05\/curs-dermo-abril-4.jpg\" width=\"255\" height=\"170\" \/><\/a><figcaption id=\"caption-attachment-13907\" class=\"wp-caption-text\">N\u00faria Bosch, vocal de Dermofarm\u00e0cia i Productes Sanitaris del COFB<\/figcaption><\/figure>\n<div class=\"box shadow\">\u201cEl c\u00e0ncer es una patologia amb una prevalen\u00e7a que augmenta amb l&#8217;edat. <strong>El pacient demana informaci\u00f3 al farmac\u00e8utic qui, per confian\u00e7a, proximitat i professionalitat, juga un paper clau en seu acompanyament durant tot el proc\u00e9s<\/strong>\u201d explica <strong>N\u00faria Bosch, vocal de Dermofarm\u00e0cia i Productes Sanitaris del Col\u00b7legi i coordinadora d\u2019aquesta formaci\u00f3<\/strong>. \u201cAbans, durant i despr\u00e9s del proc\u00e9s \u00e9s molt important cuidar la pell per evitar efectes secundaris dels tractaments i millorar aix\u00ed el seu aspecte, evitar fotosensibilitzacions, aconsellar maquillatges correctors&#8230; en definitiva, podem contribuir a mantenir una bona qualitat de vida del pacient\u201d.<\/div>\n<p>El curs ha perm\u00e8s als alumnes saber quins s\u00f3n els efectes secundaris dermatol\u00f2gics dels tractaments m\u00e9s freq\u00fcents per poder donar un consell professional acurat. \u201c<strong>Un bon consell dermofarmac\u00e8utic \u00e9s fonamental per millorar els resultats terap\u00e8utics i l\u2019adher\u00e8ncia als tractaments<\/strong>\u201d explica Bosch.<\/p>\n<div class=\"custom-divider\"><\/div>\n<p>L\u2019\u00fas d&#8217;aparells dermoanalitzadors, com a complement a la dispensaci\u00f3 de cosm\u00e8tica i productes dermofarmac\u00e8utics, permet fer <b>una recomanaci\u00f3 personalitzada amb un valor diferencial per a l\u2019usuari<\/b>. \u00c9s una possible \u00e0rea d&#8217;especialitzaci\u00f3 per a les farm\u00e0cies en la dispensaci\u00f3 i el consell dermofarmac\u00e8utic per mitj\u00e0 del diagn\u00f2stic del tipus de pell, de l\u2019estat fisiol\u00f2gic en qu\u00e8 est\u00e0 i tamb\u00e9 del grau de fotoenvelliment. <strong>Gr\u00e0cies als dermonalaitzadors les farm\u00e0cies donen un valor afegit als tractaments dermocosm\u00e8tics per a les diferents necessitats dels usuaris<\/strong>.<\/p>\n<p>Per con\u00e8ixer el seu \u00fas i la funcionalitat d\u2019aquest aparells i aprendre a utilitzar-los en situacions concretes, tant per recomanar el tractament m\u00e9s adequat com per fer seguiment dels tractaments dispensats, el Col\u00b7legi va organitzar tamb\u00e9 la formaci\u00f3 \u201cCom podem utilitzar els dermoanalitzadors?\u201d que va tenir lloc el 27 d&#8217;abril.<\/p>\n<figure id=\"attachment_13908\" aria-describedby=\"caption-attachment-13908\" style=\"width: 298px\" class=\"wp-caption alignright\"><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2015\/05\/curs-dermo-abril-5.jpg\"><img decoding=\"async\" class=\" wp-image-13908\" alt=\"curs-dermo-abril (5)\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2015\/05\/curs-dermo-abril-5.jpg\" width=\"298\" height=\"199\" \/><\/a><figcaption id=\"caption-attachment-13908\" class=\"wp-caption-text\">Montserrat Rib\u00f3 i Marta Sanz<\/figcaption><\/figure>\n<p>En aquesta formaci\u00f3, <strong>Montserrat Rib\u00f3<\/strong>, doctora en farm\u00e0cia, directora de la Unitat Dermocosm\u00e8tica i Gal\u00e8nica a l\u2019Institut de Dermatologia I. Umbert i responsable de formulaci\u00f3 magistral en una farm\u00e0cia comunit\u00e0ria, juntament amb <strong>Marta Sanz<\/strong>, farmac\u00e8utica i responsable de formaci\u00f3 de Microcaya, van repassar en una primera part te\u00f2rica els par\u00e0metres a analitzar i, a continuaci\u00f3, van organitzar una part pr\u00e0ctica per con\u00e8ixer les aplicacions i funcionament d\u2019aquests aparells.<\/p>\n<div class=\"box shadow\">Per N\u00faria Bosch, \u201cla utilitzaci\u00f3 de sistemes d\u2019an\u00e0lisis cient\u00edficament testats pot ser un<strong> element diferenciador del consell dermofarmac\u00e8utic, ja que permeten oferir seguiment i posar en valor el nostre consell<\/strong>. A la farm\u00e0cia \u00e9s important oferir producte de qualitat, consell professional, i fer un seguiment per garantir la satisfacci\u00f3 del pacient com a eina de fidelitzaci\u00f3\u201d.<\/div>\n<p style=\"text-align: right;\"><strong>Amb la col\u00b7laboraci\u00f3 de:<\/strong><\/p>\n<p style=\"text-align: right;\">\u201cAtenci\u00f3 farmac\u00e8utica dermatol\u00f2gica al pacient oncol\u00f2gic\u201d<\/p>\n<p style=\"text-align: right;\"><a href=\"http:\/\/www.eau-thermale-avene.es\/\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"alignright size-full wp-image-12843\" alt=\"avene\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2015\/04\/avene.jpg\" width=\"100\" height=\"37\" \/><\/a><\/p>\n<p style=\"text-align: right;\">\u201cCom podem utilitzar els dermoanalitzadors?\u201d<\/p>\n<p style=\"text-align: right;\"><a href=\"http:\/\/www.microcaya.com\/\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"alignright  wp-image-13904\" alt=\"microcaya\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2015\/05\/microcaya.png\" width=\"146\" height=\"53\" \/><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Tot i els aven\u00e7os en el tractament del c\u00e0ncer, els efectes secundaris que els pacients que lluiten contra aquesta malaltia poden patir s\u00f3n diversos. Sovint pensem en efectes com n\u00e0usees i debilitat, per\u00f2 tamb\u00e9 es produeixen alteracions de l\u2019aspecte f\u00edsic pels canvis que els tractaments provoquen en la pell o [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":13906,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[57],"tags":[64,81,70,76],"class_list":["post-13899","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mon-collegial","tag-atencio-farmaceutica","tag-dermofarmacia","tag-formacio","tag-oficina-de-farmacia"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Dermofarm\u00e0cia: atenci\u00f3 farmac\u00e8utica al pacient oncol\u00f2gic i \u00fas de dermoanalitzadors - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2015\/06\/11\/dermofarmacia-atencio-farmaceutica-al-pacient-oncologic-i-us-de-dermoanalitzadors\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dermofarm\u00e0cia: atenci\u00f3 farmac\u00e8utica al pacient oncol\u00f2gic i \u00fas de dermoanalitzadors - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"Tot i els aven\u00e7os en el tractament del c\u00e0ncer, els efectes secundaris que els pacients que lluiten contra aquesta malaltia poden patir s\u00f3n diversos. Sovint pensem en efectes com n\u00e0usees i debilitat, per\u00f2 tamb\u00e9 es produeixen alteracions de l\u2019aspecte f\u00edsic pels canvis que els tractaments provoquen en la pell o [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2015\/06\/11\/dermofarmacia-atencio-farmaceutica-al-pacient-oncologic-i-us-de-dermoanalitzadors\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2015-06-11T15:27:53+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/06\/11\/dermofarmacia-atencio-farmaceutica-al-pacient-oncologic-i-us-de-dermoanalitzadors\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/06\/11\/dermofarmacia-atencio-farmaceutica-al-pacient-oncologic-i-us-de-dermoanalitzadors\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Dermofarm\u00e0cia: atenci\u00f3 farmac\u00e8utica al pacient oncol\u00f2gic i \u00fas de dermoanalitzadors\",\"datePublished\":\"2015-06-11T15:27:53+00:00\",\"dateModified\":\"2015-06-11T15:27:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/06\/11\/dermofarmacia-atencio-farmaceutica-al-pacient-oncologic-i-us-de-dermoanalitzadors\/\"},\"wordCount\":837,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/06\/11\/dermofarmacia-atencio-farmaceutica-al-pacient-oncologic-i-us-de-dermoanalitzadors\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"Atenci\u00f3 farmac\u00e8utica\",\"Dermofarm\u00e0cia\",\"Formaci\u00f3\",\"Oficina de farm\u00e0cia\"],\"articleSection\":[\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2015\/06\/11\/dermofarmacia-atencio-farmaceutica-al-pacient-oncologic-i-us-de-dermoanalitzadors\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/06\/11\/dermofarmacia-atencio-farmaceutica-al-pacient-oncologic-i-us-de-dermoanalitzadors\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2015\/06\/11\/dermofarmacia-atencio-farmaceutica-al-pacient-oncologic-i-us-de-dermoanalitzadors\/\",\"name\":\"Dermofarm\u00e0cia: atenci\u00f3 farmac\u00e8utica al pacient oncol\u00f2gic i \u00fas de dermoanalitzadors - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/06\/11\/dermofarmacia-atencio-farmaceutica-al-pacient-oncologic-i-us-de-dermoanalitzadors\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/06\/11\/dermofarmacia-atencio-farmaceutica-al-pacient-oncologic-i-us-de-dermoanalitzadors\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2015-06-11T15:27:53+00:00\",\"dateModified\":\"2015-06-11T15:27:53+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/06\/11\/dermofarmacia-atencio-farmaceutica-al-pacient-oncologic-i-us-de-dermoanalitzadors\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2015\/06\/11\/dermofarmacia-atencio-farmaceutica-al-pacient-oncologic-i-us-de-dermoanalitzadors\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/06\/11\/dermofarmacia-atencio-farmaceutica-al-pacient-oncologic-i-us-de-dermoanalitzadors\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/06\/11\/dermofarmacia-atencio-farmaceutica-al-pacient-oncologic-i-us-de-dermoanalitzadors\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dermofarm\u00e0cia: atenci\u00f3 farmac\u00e8utica al pacient oncol\u00f2gic i \u00fas de dermoanalitzadors\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Dermofarm\u00e0cia: atenci\u00f3 farmac\u00e8utica al pacient oncol\u00f2gic i \u00fas de dermoanalitzadors - Col\u00b7legi de Farmac\u00e8utics de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2015\/06\/11\/dermofarmacia-atencio-farmaceutica-al-pacient-oncologic-i-us-de-dermoanalitzadors\/","og_locale":"ca_ES","og_type":"article","og_title":"Dermofarm\u00e0cia: atenci\u00f3 farmac\u00e8utica al pacient oncol\u00f2gic i \u00fas de dermoanalitzadors - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"Tot i els aven\u00e7os en el tractament del c\u00e0ncer, els efectes secundaris que els pacients que lluiten contra aquesta malaltia poden patir s\u00f3n diversos. Sovint pensem en efectes com n\u00e0usees i debilitat, per\u00f2 tamb\u00e9 es produeixen alteracions de l\u2019aspecte f\u00edsic pels canvis que els tractaments provoquen en la pell o [&hellip;]","og_url":"https:\/\/novaorg.cofb.net\/2015\/06\/11\/dermofarmacia-atencio-farmaceutica-al-pacient-oncologic-i-us-de-dermoanalitzadors\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2015-06-11T15:27:53+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"wpAdminCofbOrg","Temps estimat de lectura":"4 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2015\/06\/11\/dermofarmacia-atencio-farmaceutica-al-pacient-oncologic-i-us-de-dermoanalitzadors\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2015\/06\/11\/dermofarmacia-atencio-farmaceutica-al-pacient-oncologic-i-us-de-dermoanalitzadors\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Dermofarm\u00e0cia: atenci\u00f3 farmac\u00e8utica al pacient oncol\u00f2gic i \u00fas de dermoanalitzadors","datePublished":"2015-06-11T15:27:53+00:00","dateModified":"2015-06-11T15:27:53+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2015\/06\/11\/dermofarmacia-atencio-farmaceutica-al-pacient-oncologic-i-us-de-dermoanalitzadors\/"},"wordCount":837,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2015\/06\/11\/dermofarmacia-atencio-farmaceutica-al-pacient-oncologic-i-us-de-dermoanalitzadors\/#primaryimage"},"thumbnailUrl":"","keywords":["Atenci\u00f3 farmac\u00e8utica","Dermofarm\u00e0cia","Formaci\u00f3","Oficina de farm\u00e0cia"],"articleSection":["M\u00f3n col\u00b7legial"],"inLanguage":"ca","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2015\/06\/11\/dermofarmacia-atencio-farmaceutica-al-pacient-oncologic-i-us-de-dermoanalitzadors\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2015\/06\/11\/dermofarmacia-atencio-farmaceutica-al-pacient-oncologic-i-us-de-dermoanalitzadors\/","url":"https:\/\/novaorg.cofb.net\/2015\/06\/11\/dermofarmacia-atencio-farmaceutica-al-pacient-oncologic-i-us-de-dermoanalitzadors\/","name":"Dermofarm\u00e0cia: atenci\u00f3 farmac\u00e8utica al pacient oncol\u00f2gic i \u00fas de dermoanalitzadors - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2015\/06\/11\/dermofarmacia-atencio-farmaceutica-al-pacient-oncologic-i-us-de-dermoanalitzadors\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2015\/06\/11\/dermofarmacia-atencio-farmaceutica-al-pacient-oncologic-i-us-de-dermoanalitzadors\/#primaryimage"},"thumbnailUrl":"","datePublished":"2015-06-11T15:27:53+00:00","dateModified":"2015-06-11T15:27:53+00:00","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2015\/06\/11\/dermofarmacia-atencio-farmaceutica-al-pacient-oncologic-i-us-de-dermoanalitzadors\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2015\/06\/11\/dermofarmacia-atencio-farmaceutica-al-pacient-oncologic-i-us-de-dermoanalitzadors\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/novaorg.cofb.net\/2015\/06\/11\/dermofarmacia-atencio-farmaceutica-al-pacient-oncologic-i-us-de-dermoanalitzadors\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2015\/06\/11\/dermofarmacia-atencio-farmaceutica-al-pacient-oncologic-i-us-de-dermoanalitzadors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Dermofarm\u00e0cia: atenci\u00f3 farmac\u00e8utica al pacient oncol\u00f2gic i \u00fas de dermoanalitzadors"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"Tot i els aven\u00e7os en el tractament del c\u00e0ncer, els efectes secundaris que els pacients que lluiten contra aquesta malaltia poden patir s\u00f3n diversos. Sovint pensem en efectes com n\u00e0usees i debilitat, per\u00f2 tamb\u00e9 es produeixen alteracions de l\u2019aspecte f\u00edsic pels canvis que els tractaments provoquen en la pell o [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/13899","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=13899"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/13899\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=13899"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=13899"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=13899"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}